详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Chan, Henry Lik Yuen[1] * ; Lim, Young-Suk[2] ; Hou, JinLin[3] ; Hui, Aric Josun[4] ; Seto, Wai-Kay[5] ; Chang, Ting-Tsung[6] ; Chuang, Wan-Long[7] ; Janssen, Harry L. A.[8] ; Fung, Scott K.[9] ; Ning, Qin[10]

; Izumi, Namiki[11] ; Flaherty, John F.[12] ; Suri, Vithika[12] ; Wang, Hongyuan[12] ; Manukyan, Avet[13] ; Shen, Sophie[13] ; Temme, Lauren[12] ; Osinusi, Anu O.[12] ; Agarwal, Kosh[14] ; Buti, Maria[15] ; Gane, Edward J.[16,17] ;

单位： [1]Chinese Univ Hong Kong, Hong Kong, Peoples R China [2]Univ Ulsan, Coll Med, Ctr Liver, Dept Gastroenterol,Asan Med Ctr, Ulsan, South Korea [3]Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China [4]Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Peoples R China [5]Univ Hong Kong, Med, Hong Kong, Peoples R China [6]Minist Hlth & Welf, Clin Task Force, Natl Hepatitis C Program Off, Kaohsiung, Taiwan [7]Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan [8]Toronto Gen Hosp, Res Inst, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada [9]Univ Toronto, Med, Toronto, ON, Canada [10]Tongji Hosp, Wuhan, Peoples R China [11]Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan [12]Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA [13]UCSF Sch Pharm, San Francisco, CA USA [14]Kings Coll Hosp London, Inst Liver Studies, London, England [15]Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain [16]Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand [17]Univ Auckland, Auckland, New Zealand

出处：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

JCR分区：

出版当年[2019]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

第一作者：

第一作者单位： [1]Chinese Univ Hong Kong, Hong Kong, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

IMPACT OF LONG-TERM ORAL ANTIVIRAL (OAV) TREATMENT ON HEPATOCELLULAR CARCINOMA (HCC) RISK IN IMMUNE-TOLERANT AND IMMUNE-ACTIVE CHRONIC HEPATITIS B PATIENTS (CHB) UTILIZING AMAP, A RECENTLY VALIDATED RISK PREDICTION TOOL

文献详情